The invention relates to chiral
iridium hydride complexes comprising a) chiral (P,N)-ligand and b) a stabilizing
enone ligand of formula (I) wherein R1 is selected from the group consisting of
hydrogen, C1-C500-
alkyl, C2-C500-alkenyl, C1-C500- alkoxy, C2-C500-alkenyloxy, C1-C500-alkylamino, C2-C500-alkenylamino, di-(C1-C500-
alkyl)amino, di-(C2-C500-alkenyl)amino, N-(C1-C500-
alkyl)-N-(C2-C500-alkenyl)amino, C3-C8- cycloalkyl, C3-C8 -cycloalkoxy, C3-C8-cycloalkylamino, N-(C1-C500-alkyl)-N-(C3-C8- cycloalkyl)amino, C6-C14-
aryl, which may be substituted as further defined in the specification, R1a is selected from the group consisting of
hydrogen, C1-C6-alkyl, C1-C6 -alkylcarbonyl, or R1a and R1 form together with the
carbon atom to which R1a is attached and the
carbonyl group to which R1 is attached a C5-C7-cycloalkanone ring, wherein the C5-C7-cycloalkanone ring is unsubstituted or substituted by one to four substituents selected independently from each other from C1-C6- alkyl, and benzylidene, wherein the benzylidene is unsubstituted or substituted by one to five substituents selected independently from each other from
halogen, C1-C500-alkyl, C1-C500-alkoxy, C1-C500-haloalkyl, and C1-C500-haloalkoxy, R2 is selected from the group consisting of
hydrogen, C1-C500-alkyl, C1-C500-; C1-C500- alkylamino, di-(C1-C500-alkyl)amino, C3-C8-cycloalkyl, C3-C8-cycloalkoxy, C3-C8- cycloalkylamino, N-(C1-C500-alkyl)-N-(C3-C8-cycloalkyl)amino, C6-C14-
aryl, which may be substituted as further defined in the specification, and the arrow indicates a bond to the
iridium atom, as well as to a process for preparing
optically active 4-substituted 1,2,3,4-tetrahydroquinolines by enantioselective hydrogenation of the corresponding 4-substituted 1,2-dihydroquinolines in presence of such chiral
iridium hydride complex.